Jason T Lewis

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases
    Jason T Lewis
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 36:517-25. 2012
  2. ncbi request reprint Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:907-13. 2007
  3. ncbi request reprint An analysis of breast cancer risk in women with single, multiple, and atypical papilloma
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 30:665-72. 2006
  4. ncbi request reprint Crystal-storing histiocytosis due to massive accumulation of charcot-leyden crystals: a unique association producing colonic polyposis in a 78-year-old woman with eosinophilic colitis
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:481-5. 2007
  5. doi request reprint Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 32:566-71. 2008
  6. pmc Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus
    Ganapathy A Prasad
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Gastroenterol 102:2380-6. 2007
  7. pmc Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma
    Rami J Badreddine
    Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 8:248-53. 2010
  8. doi request reprint Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma
    Jason T Lewis
    Division of Anatomic Pathology, Department of Pathology, DeKalb Medical Center, Decatur, GA 30033, USA
    Am J Surg Pathol 34:27-34. 2010
  9. doi request reprint Diagnostic performance of two confocal endomicroscopy systems in detecting Barrett's dysplasia: a pilot study using a novel bioprobe in ex vivo tissue
    Emmanuel C Gorospe
    Barrett s Esophagus Unit, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 76:933-8. 2012
  10. pmc Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus
    Eric M Nelsen
    Division of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Clin Gastroenterol Hepatol 10:728-34; quiz e61-2. 2012

Detail Information

Publications22

  1. doi request reprint Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases
    Jason T Lewis
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 36:517-25. 2012
    ..On the basis of the locally aggressive nature of this lesion we believe it is best considered a low-grade sarcoma and suggest the term low-grade sinonasal sarcoma with neural and myogenic features...
  2. ncbi request reprint Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:907-13. 2007
    ..The strong correlation between gallbladder dysplasia/adenocarcinoma and bile duct dysplasia/CC supports the concept of a neoplastic "field effect" along the intrahepatic and extrahepatic biliary tract in PSC...
  3. ncbi request reprint An analysis of breast cancer risk in women with single, multiple, and atypical papilloma
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 30:665-72. 2006
    ..The presence of papilloma in, or associated with, atypia does not modify the risk connotation of ADH/ALH overall. MP constitutes a proliferative breast disease subset having unique clinical and biologic behavior...
  4. ncbi request reprint Crystal-storing histiocytosis due to massive accumulation of charcot-leyden crystals: a unique association producing colonic polyposis in a 78-year-old woman with eosinophilic colitis
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:481-5. 2007
    ..This is the first reported case of crystal-storing histiocytosis produced by massive accumulation of Charcot-Leyden crystals in eosinophilic colitis...
  5. doi request reprint Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma
    Jason T Lewis
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 32:566-71. 2008
    ....
  6. pmc Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus
    Ganapathy A Prasad
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Gastroenterol 102:2380-6. 2007
    ..The aim of this study was to assess the accuracy of tumor staging by EMR using esophagectomy as the standard...
  7. pmc Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma
    Rami J Badreddine
    Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 8:248-53. 2010
    ..We evaluated the impact of depth of submucosal invasion on the presence of metastatic lymphadenopathy and survival in patients with esophageal adenocarcinoma...
  8. doi request reprint Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma
    Jason T Lewis
    Division of Anatomic Pathology, Department of Pathology, DeKalb Medical Center, Decatur, GA 30033, USA
    Am J Surg Pathol 34:27-34. 2010
    ..Dysplasia, however, is generally confined to large and septal-size bile ducts and its presence may not be recognized unless multiple sections specifically targeted to the biliary tree are examined...
  9. doi request reprint Diagnostic performance of two confocal endomicroscopy systems in detecting Barrett's dysplasia: a pilot study using a novel bioprobe in ex vivo tissue
    Emmanuel C Gorospe
    Barrett s Esophagus Unit, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 76:933-8. 2012
    ..The diagnostic performance of these 2 systems has not been directly compared...
  10. pmc Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus
    Eric M Nelsen
    Division of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Clin Gastroenterol Hepatol 10:728-34; quiz e61-2. 2012
    ..This association might be mediated by mechanical and endocrine mechanisms. We investigated the distribution of fat in subjects with BE and its association with esophageal inflammation and dysplasia...
  11. doi request reprint Outcomes of T1b esophageal adenocarcinoma patients
    Jianmin Tian
    Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 74:1201-6. 2011
    ..Endoscopic management often differs based on the risk of metastasis. There is limited information on the difference in outcomes for T1b-EAC with and without esophagectomy...
  12. pmc Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus
    Ganapathy A Prasad
    Division of Gastroenterology and Hepatology, 200 First Street SW, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Gastroenterol Hepatol 4:173-8. 2006
    ..Frozen sections help to give immediate feedback for surgical procedures. It has not been determined whether EMR can be adequately interpreted by using frozen sections to aid endoscopists in completely resecting neoplastic lesions...
  13. ncbi request reprint Breast cancer risk in women with radial scars in benign breast biopsies
    Jena C Berg
    Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 108:167-74. 2008
    ..We studied the relative risk of radial scar lesions in a large cohort of patients with benign breast disease (BBD)...
  14. doi request reprint IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis
    Lizhi Zhang
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 34:88-94. 2010
    ..PSC with tissue IgG4 positivity has a more aggressive clinical course manifested by shorter time to transplant and a higher likelihood of recurrence than IgG4 negative PSC...
  15. doi request reprint Observer variability in the histologic diagnosis of microscopic colitis
    David Limsui
    Division of Gastroenterology and Hepatology, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Inflamm Bowel Dis 15:35-8. 2009
    ..There has been no investigation of the reproducibility of the histologic diagnosis of microscopic colitis. Our aim was to evaluate interobserver and intraobserver variation in this diagnosis...
  16. ncbi request reprint The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma
    Ivana N M Micallef
    Divison of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Leuk Lymphoma 47:1794-9. 2006
    ..In conclusion, tIPI at the time of histological transformation is an important predictor of OS. A time to transformation > 4 years from diagnosis is associated with better OS...
  17. doi request reprint Predictors of recurrent esophageal food impaction: a case-control study
    Ganapathy A Prasad
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Gastroenterol 42:771-5. 2008
    ..Knowledge of factors predisposing to recurrent FI may enable preventive measures to minimize the risk of recurrence...
  18. pmc Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma
    Xiaoke Wang
    1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA 2
    Nat Genet 46:666-8. 2014
    ..The SNS phenotype is characterized by aberrant expression of genes involved in neuroectodermal and myogenic differentiation, closely simulating the developmental roles of PAX3. ..
  19. pmc Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force
    Shigao Chen
    Department of Biomedical Engineering, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Radiology 266:964-70. 2013
    ....
  20. doi request reprint Angiogenesis and CD34 expression as a predictor of recurrence in oral squamous cell carcinoma
    Deepak Kademani
    Mayo Clinic, College of Medicine, Rochester, MN 55905, USA
    J Oral Maxillofac Surg 67:1800-5. 2009
    ..The identification of prognostic markers of early lymph node involvement in OSCC could allow for the use of more targeted biologic therapies for patients with early-stage tumors...
  21. ncbi request reprint Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining
    Jason T Lewis
    Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Am J Clin Pathol 124:273-81. 2005
    ..In the nonamplified cases, 17 (94%) showed no amplification in repeated FISH. Significant intratumoral heterogeneity and minimal (low-level) HER-2 amplification account for many breast cancers with 2+ HER-2 protein expression...
  22. ncbi request reprint Glycogen pseudoground glass change in hepatocytes
    Joshua Wisell
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA
    Am J Surg Pathol 30:1085-90. 2006
    ..The changes are generally seen in the background of mild chronic hepatitis with mild or no fibrosis. Glycogen pseudoground glass change can resolve, but may also persist for years...